ASHLEY TOUCHTON: Open Payments
NPI 1679962146 · GEORGETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 25 payments from 13 companies in 2025. Trend: 2023 $136 · 2024 $428 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Novo Nordisk Inc | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Lilly USA, LLC | 3 | $57 |
| PFIZER INC. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $37 |
| Amgen Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $21 |
| Braeburn Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: Ozempic, BREZTRI, MOUNJARO, VRAYLAR, SPRAVATO, OTEZLA, QULIPTA, REXULTI.
Industry payments across DE — which companies pay providers there.
